The Nanōmix eLab® System

Nanomix elab®*

elab system



Point of Care Testing with the Nanōmix eLab® System

The the Nanōmix eLab® system is a mobile, hand-held immunoassay and chemistry diagnostic system designed for the needs of rapid Point-of-Care testing. The Nanōmix eLab offers the benefits of results in minutes, low cost, and portability while providing accurate, quantitative results comparable in quality to those provided by central lab testing.



Nanomix eLab

The Nanōmix eLab® system utilizes patented multi-plex test cartridge technology designed to broadly impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings.Nanōmix’s first assays address the critical needs for faster diagnosis of critical infections as well as the rapid identification of SARS-CoV-2 infection. The company is developing a deep pipeline of other tests designed to improve patient outcomes by making high-quality diagnostic information available within minutes.






Assays for the eLab System

*The Nanōmix eLab® and S1 Panel Cartridge has not yet been FDA reviewed or cleared for sale in the U.S. It is not commercially available in the U.S.
The Nanōmix eLab® and S1 Panel has received CE Mark and MHRA Registration.
The Nanōmix eLab® COVID-19 Rapid Antigen Test is not commercially available in the U.S.
The Nanōmix eLab® COVID-19 Rapid Antigen Test has received CE Mark.
Other assays in development